Approvals/TGA/VYEPTI eptinezumab 100 mg/mL concentrated injection single use vial

Approved

STANDARD

VYEPTI eptinezumab 100 mg/mL concentrated injection single use vial

Lundbeck Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: fbe0a628d260d06d
Product Name: VYEPTI eptinezumab 100 mg/mL concentrated injection single use vial
Artg Id: 335256
Artg Name: VYEPTI eptinezumab 100 mg/mL concentrated injection single use vial
Sponsor: Lundbeck Australia Pty Ltd
Company Detail Path: /organization/lundbeck-australia-pty-ltd
Artg Date: 2021-06-16
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/f85c018f85d9a3d059f48fb47f0218e4.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/ce14b940fca0ae4fc0c7ba2ebc546316.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

fbe0a628d260d06d

Type

Standard